Deliver Your News to the World

SkinzWraps, Inc. (OTC: SKZW) Unveils High Efficiency Training Program


(CybeRelease, April 20, 2006 ) - Lake Harmony, PA - SkinzWraps, Inc. (Pink Sheets: SKZW), a full-service vehicle wrapping company, today revealed details about its proprietary employee-training program.

``We’ve developed a unique training and certification process over the past three years in an effort to build the absolute best team of installers in the industry,’’ stated CEO Peter Salaverry. ``The result is a more efficient and effective system. What used to take up to a year of training with plenty of trial and error can now be done in 60 days with a 99% success rate, thanks in large part to the experience and expertise of our master installers, who’ve been with us from the beginning.’’

The 250-hour training program turns new employee recruits into apprentice installers in just two months through an intense, hands-on approach. Following a brief introduction, trainees hone their skills in the company’s unique, vehicle-wrapping simulator, which allows them to work through a full spectrum of different vehicle shapes and surfaces simultaneously. This meticulous, step-by-step process of installing and uninstalling wraps uses only recycled scrap material, so the hard costs are negligible.

``Having this program in place is one of the keys to our national growth strategy,’’ Salaverry added. ``Being able to quickly train and certify installers here in Dallas enables us to scale up quickly to meet demand and also to send teams anywhere in the country, wherever the clients may be. We eventually plan to build SkinsWraps training and certification centers at each of our other locations.’’

SkinzWraps qualifies three levels of installers: apprentice, installer, and master installer. The latter two oversee all of the company’s warranted wraps.

For a Free Newsletter and more information, go to

CybeRelease Gainers are Aehr Test Systems (Nasdaq: AEHR), Monogram Biosciences, Inc. (Nasdaq: MGRM), Cresud S.A.C.I.F. y A. (Nasdaq: CRESY), On Assignment, Inc. (Nasdaq: ASGN), BioDelivery Sciences International, Inc. (Nasdaq: BDSI), Clinical Data, Inc. (Nasdaq: CLDA), ICU Medical, Inc. (Nasdaq: ICUI) and Medicines Company (The) (Nasdaq: MDCO).

CybeRelease Decliners are Wegener Corporation (Nasdaq: WGNR), Genzyme General (Nasdaq: GENZ), Ronson Corporation (Nasdaq: RONC), AB Volvo (Nasdaq: VOLVY), First Cash Financial Services, Inc. (Nasdaq: FCFS), Stanley Furniture Company, Inc. (Nasdaq: STLY), Pizza Inn, Inc. (Nasdaq: PZZI) and Oralabs Holding Corp. (Nasdaq: OLAB).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $595.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.